|
|
|
 |
|
| Press Room |
 |
|
Welcome to the American Cancer Society Press Room. Here you can browse our press releases, search our archives, and find details about our most recent announcements.
|
 |
| Learn current information about the American Cancer Society, as well as more about the Society's history, research milestones, and leadership.
|
 |
| Uncover the truth about recent cancer rumors, stories about ACS, internet hoaxes, and email chain letters.
|
 |
|
Dr. Len's Cancer Blog, authored by J. Leonard (Len) Lichtenfeld, MD, the Society's deputy chief medical officer, covers
breaking cancer news and provides commentary on new research, scientific developments, and other cancer
breakthroughs.
|
 |
 |
| Access the most up-to-date press releases and announcements from ACS.
|
 |
|
 |
|
Access the most up-to-date press releases and announcements from ACS.
|
 |
 |
American Cancer Society Hope Lodge to Receive $100,000 Thanks to Drew Brees and Pepsi Refresh Project
Statement of John R. Seffrin, PhD, Chief Executive Officer, American Cancer Society |
 |
 |
American Cancer Society to Manage New Effort Against Tobacco in Africa
The Bill & Melinda Gates Foundation has given a grant of $7 million over five years to the American Cancer Society to lead and coordinate the African Tobacco Control Consortium. |
 |
 |
American Cancer Society, Competitor Group,Launch Rock ‘n’ Roll Marathon Collaboration
The American Cancer Society and the Competitor Group, Inc., today announced a new collaboration to empower endurance athletes of all abilities to take a more proactive role in improving their personal health and saving lives from cancer. |
 |
 |
Prostate cancer therapy can increase heart risk factors
Androgen-deprivation therapy (ADT), commonly used to treat prostate cancer, can worsen heart risk factors and may increase the risk of heart attack and/or cardiac death according to a new report. |
 |
 |
Liver Cancer Patients Face Racial Disparities in Survival, Despite Receiving Equal Treatment
A new analysis has found that Black patients with hepatocellular carcinoma (HCC), or liver cancer, have worse survival than patients of other races, even after receiving comparable treatments. |
 |  |
|
|
|